ArticleMolecules (Basel, Switzerland)2025
Enhanced Infrared Shielding Function in ATO-Doped Polymer-Dispersed Liquid Crystal Films.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The enhanced infrared shielding function of antimony tin oxide (ATO)-doped polymer-dispersed liquid crystal (PDLC) film enables its use for smart windows, because it can switch between transparent and scattered states, which can protect people's privacy. When PDLC film is used for a building's doors and windows or external walls, we hope that it can have a higher infrared shielding capability, in order to reduce the indoor temperature affected by solar irradiation, so as to reduce the energy consumption caused by refrigeration equipment. However, the infrared shielding capability of the existing PDLC is far from sufficient. In this work, modified ATO nanoparticles of different sizes were introduced into the PDLC system to improve its infrared shielding capability. It was found that when the ATO particle size is 20 nm and the doping content is 0.6 wt%, the modified PDLC sample provides optimal infrared shielding function while maintaining excellent electro-optical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.